Search the web
Welcome, Guest
[Sign Out, My Account]
Morningstar_Inc.

Friday, December 9 2016 10:22pm ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology
More On This Industry
Summary
·News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
  
Industry Market Summary
Biotechnology
Composite Value: 1490.9
Today's Change: +0.65%
S&P 500: +0.36%
chart for
[Biotechnology (^YHOh788)]
Biotechnology News
Ohr Pharmaceuticals Expects $8M from Public Offering
2 hours, 52 minutes ago (at Investopedia)
Ohr Pharmaceuticals plans to use the proceeds of its stock offering to fund drug studies.
Gilead Files New Drug Application for Hep C Combo - (at Investopedia)
INVESTOR ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Alexion Pharmaceuticals, Inc. (ALXN) & Lead Plaintiff Deadline - January 17, 2017 - ()
More News on Biotechnology: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
SHIRE PLC ORD 5P [SHP.L] +2.36% $3922.2 B
ROCHE HOLDING AG [ROGN.MX] 0.00% $3822.8 B
AMGEN INC. [AMGN.MX] 0.00% $2130.2 B
GILEAD SCIENCES INC. [GILD.MX] 0.00% $1944.0 B
CELGENE CORPORATION [CELG.MX] +1.09% $1771.3 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
12/08/16 ONCS OncoSec Medical Inc Q1 2017 Earnings Release
12/12/16 PPHM Peregrine Pharmaceuticals Inc Q2 2017 Earnings Release
12/14/16 ARWR Arrowhead Pharmaceuticals Inc Q4 2016 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
12/08/16 BMRN BioMarin Pharmaceutical Inc. coverage initiated by Gabelli & Co
12/07/16 AMBS AMARANTUS BIOSCIEN COM USD0.001 downgraded by WallachBeth
12/07/16 AXON Axovant Sciences Ltd. Common Sh coverage initiated by Oppenheimer
More Recent Events...
  
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:457B
Price / Earnings:165.8
Price / Book:23.4
Net Profit Margin (mrq):19.7%
Price To Free Cash Flow (mrq):-290.2
Return on Equity:15.4%
Total Debt / Equity:116.1
Dividend Yield:2.4%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
CTRX
PGLAF
NRPH
Unusually Active Boards
Board Variance
CTRX
NRPH
PDLI

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?